Hepatitis C illustration as blue cells. Credit: Shutterstock

Monitoring hepatitis C treatment uptake in Australia Issue 2, June 2016

This report summarises data on the prescription and distribution of hepatitis C treatments and provides insight into the initial phase of the roll-out of DAA therapy in Australia. 

Key findings
  • A total of 6,503 patient PBS initial prescriptions were processed for reimbursement in March – April 2016.
  • Based on extrapolation of wholesale data to PBS reimbursement data, to account for the time lag in reporting, an estimated 13,000 – 16,250 patients initiated hepatitis C treatment in March-April 2016.
Monitoring hepatitis C treatment uptake in Australia Issue 2, June 2016 796.2 KB pdf
Report contact
Year published
2016
Report type
Research reports
Latest news